πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,639 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7744934

Methods for modulating eicosanoid metabolism

The Board of Regents of the University of Texas System Β· Granted Tue Jun 29 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7744851

Methods and agents for preparing 18F-radiolabeled fluorinating agents

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Tue Jun 29 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7741091

Methods of producing hyaluronic acid and chimeric and hybrid glycosaminoglycan polymers

The Board of Regents of the University of Oklahoma Β· Granted Tue Jun 22 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 17 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7740867

Method for identification of virulence determinants

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Tue Jun 22 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 17 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7737266

RNAi modulation of SCAP and therapeutics uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Jun 15 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 10 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7736646

Methods for modulating angiogenesis with apelin compositions

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue Jun 15 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 10 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7732470

Compositions and methods for the treatment of renal and cardiovascular disease

The Board of Regents of the University of Texas System Β· Granted Tue Jun 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7732576

Tumor suppressor designated TS10Q23.3

The Board of Regents of the University of Texas System Β· Granted Tue Jun 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7727554

Sustained-release nanoparticle compositions and methods for using the same

Board of Regents of the University of Nebraska by and behalf of the University of Nebraska Medical Center Β· Granted Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7723375

Metabolites of wortmannin analogs and methods of using the same

Arizona Board of Regents, Acting on Behalf of the University of Arizona Β· Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7723104

Cancer specific promoters

The Board of Regents of the University of Texas System Β· Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7718387

Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using E

The Board of Regents of the University of Texas System Β· Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7718160

Radiolabeled compounds and liposomes and their method of making and using same

The Board of Regents of the University of Texas System Β· Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7714007

Method of alleviating chronic pain via peripheral glutaminase regulation

The Board of Regents of the University of Oklahoma Β· Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7714109

Combinations and kits for cancer treatment using selected antibodies to aminophospholipids

The Board of Regents of the University of Texas System Β· Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7713934

Thrombin peptide derivatives

The Board of Regents of the University of Texas System Β· Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7709190

Influenza A virus vaccines and inhibitors

The Board of Regents of the University of Texas System Β· Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7709643

Synthesis of sodium narcistatin and related compounds

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7709625

Methods and compositions for bone marrow stem cell-derived macrophage delivery of genes fo

The Board of Regents of the University of Texas Β· Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7709456

Modulation of gene expression by oligomers targeted to chromosomal DNA

The Board of Regents of the University of Texas System Β· Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7704962

Small oligonucleotides with anti-tumor activity

The Board of Regents of the University of Texas System Β· Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7705188

Structural modification of resveratrol: sodium resverastatin phosphate

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7704985

Treatment of irritable bowel syndrome and related bowel diseases

The Board of Regents of the University of Texas System Β· Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7704497

Molecules with extended half-lives, compositions and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted